Edition:
United Kingdom

Cidara Therapeutics Inc (CDTX.OQ)

CDTX.OQ on NASDAQ Stock Exchange Global Market

2.30USD
23 Apr 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
$2.30
Open
$2.31
Day's High
$2.50
Day's Low
$2.29
Volume
39,587
Avg. Vol
24,964
52-wk High
$6.35
52-wk Low
$1.96

About

Cidara Therapeutics Inc., is a clinical-stage biotechnology company focused on developing new anti-infectives. The Company’s lead product candidate is rezafungin acetate, which is a molecule in the echinocandin class of antifungals for the treatment and prevention of serious invasive fungal infections, including candidemia and... (more)

Overall

Beta: 2.19
Market Cap(Mil.): $64.53
Shares Outstanding(Mil.): 27.82
Dividend: --
Yield (%): --

Financials

  CDTX.OQ Industry Sector
P/E (TTM): -- 110.59 62.94
EPS (TTM): -2.87 -- --
ROI: -93.55 8.01 11.75
ROE: -116.66 8.19 12.58

Earnings vs. Estimates